Reneo Pharmaceuticals Inc

NASDAQ:RPHM  
6.06
-0.24 (-3.81%)
Earnings Announcements

Reneo Pharmaceuticals Posts Q3 Loss Per Share Of $0.52

Published: 11/11/2021 22:19 GMT
Reneo Pharmaceuticals Inc (RPHM) - Reneo Pharmaceuticals Reports Third Quarter 2021 Financial Results.
Q3 Loss per Share $0.52.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.57

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.61

More details on our Analysts Page.